Netcompany’s UK Country Managing Partner Richard Davies says the £215m (US$290m) partnership with NHS England will deliver ...
As UK pharmacies begin offering Eli Lilly’s oral GLP-1 Foundayo, Crane Authentication’s Heather Clarke-Hite says technology ...
David Niewolny, NVIDIA’s Director of Healthcare Business Development, unpacks the opportunities, barriers and prospects ...
From Tempus AI and ZAIDYN to Salesforce and Veeva Systems, Healthcare Digital explores the leading agentic AI platforms ...
As Chief Corporate Affairs and Sustainability Officer, Jonathan Rose will lead Bupa APAC’s communications, public affairs, ...
Andrea Haegebarth will join Novo Nordisk as SVP of Global Research, while Jacob Petersen will take on the role of Head of R&D External Innovation Novo Nordisk has announced a reshuffle in its research ...
Sweden is aiming to ban PFAS chemicals in a bid to curb human exposure, with Minister Erik Slottner emphasising the move's ...
Eli Lilly’s GLP-1 portfolio includes Type 2 diabetes medications Mounjaro and Trulicity, as well as oral GLP-1 pill Foundayo designed to tackle weight management and type 2 diabetes. Credit: Pexels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results